Table III.
Detailed data and results of studies with outcomes of physical examination and laboratory data
| Study | Group | Age, years Mean±SD |
Sex,M:F n |
SBP, mmHg Mean±SD |
DBP, mmHg Mean ± SD |
Total cholesterol, mg/dl Mean±SD |
LDL, mg/dl Mean ±SD |
HDL, mg/dl Mean±SD |
TG, mg/dl Mean±SD |
CRP, mg/dl Mean±SD |
FBG, mg/dl Mean±SD |
CIMT, mm Mean±SD |
EFT, mm Mean ±SD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duman et al (9), 2014 | Rosacea | 44.70± 12.90 | 20:40 | 199.19 ±36.60 | 121.02±31.54 | 53.80 ± 14.06 | 119.05 ±53.93 | 0.429 | |||||
| Control | 42.30± 12.30 | 17:33 | 162.83 ±30.05 | 101.48±23.47 | 50.17 ±8.43 | 121.94±64.57 | 0.423 | ||||||
| Tsiskarishvili et al. (34), 2015 | Rosacea | 35–65a | 20:30 | 280.25 ±24.33 | 180.00± 19.75 | 24.00 ±5.62 | 234.50 ±27.45 | ||||||
| Control | 35–65a | 20:30 | 190.60 ±10.40 | 135.00± 12.40 | 45.70 ±8.90 | 170.50 ±11.5 | |||||||
| Belli et al. (36), 2016 | Rosacea | 50.80 | 12:35 | 127.45 ±17.35 | 81.49± 8.34 | 218.53 ±33.37 | 132.96±31.21 | 58.96 ±15.75 | 131.49 ±69.6 | 4.86 ±12.86 | 96.57 ±13.05 | ||
| Control | 50.90 | 11:39 | 118.60 ±15.25 | 76.00± 8.81 | 201.80 ±36.48 | 119.84± 27.46 | 59.20 ±17.22 | 103.26 ±50.25 | 2.78 ±4.93 | 92.48 ±6.89 | |||
| Belli et al. (37), 2017a | Rosacea | 50.50 ±8.60 | 16:45 | 126.80 ±16.71 | 82.29± 9.20 | 214±35.47 | 129.87 ±31.46 | 57.19 ± 14.51 | 83.09 ± 8.79 | 3.33 ±3.11 | 96.42 ± 14.53 | ||
| Control | 49.80 ±9.70 | 13:47 | 118.50 ± 14.12 | 75.83± 9.26 | 199.76 ±34.89 | 119.00±26.39 | 57.62 ±16.69 | 76.04± 9.39 | 2.26 ±2.22 | 91.83 ±7.36 | |||
| Belli et al. (38), 2017b | Rosacea | 50.60 ±8.50 | 20:65 | 212.71 ±36.27 | 129.56±31.58 | 55.91 ±13.79 | 135.39 ± 70.31 | 3.35 ±3.31 | 96.71 ± 14.27 | ||||
| Control | 50.8o±9.00 | 23:67 | 204.14±33.53 | 121.91 ± 25.43 | 57.59 ± 16.47 | 117.23 ± 54.49 | 2.33 ±2.13 | 93.56 ±9.05 | |||||
| Belli et al. (39), 2017c | Rosacea | 50.40 ± 7.60 | 9:31 | 123.14± 16.94 | 80.00± 10.57 | 215.54±40.78 | 133.74± 33.39 | 53.89 ±12.31 | 141.45 ± 75.06 | 3.16 ±3.16 | 95.97 ± 14.96 | 0.72± 0.19 | 4.46 ±0.65 |
| Control | 50.50 ± 8.00 | 10:30 | 114.36 ± 14.11 | 74.61 ± 6.82 | 206.31 ± 30.45 | 121.76±24.68 | 59.87 ± 16.98 | 123.24±59.11 | 2.26 ±1.99 | 94.49 ±11.46 | 0.61 ± 0.12 | 3.28 ±0.59 | |
| Sinikumpu et al. (33), 2019 | Rosacea | 46 | 0:146 | 121.61 ±15.47 | 83.78± 9.96 | 200.77 ± 30.89 | 124.71 ± 30.12 | 64.86± 15.44 | 97.35±52.21 | 1.9 ±3.5 | 93.69 ± 14.41 | 0.61 ± 0.074 | |
| Control | 46 | 0:278 | 118.62 ±15.07 | 82.09± 10.19 | 198.84±31.27 | 123.55±29.73 | 64.48± 15.06 | 94.69 ±50.44 | 1.4±2.3 | 92.79 ±9.08 | 0.59± 0.067 | ||
| Gurel et al. (40), 2019 | Rosacea | 50.70 ±7.90 | 23:29 | 121.54± 18.51 | 76.15± 11.90 | 211.61 ±43.82 | 126.21 ± 36.58 | 54.4± 11.52 | 154.71 ±90.46 | 3.06 ±2.66 | 0.692 ±0.068 | 5.61 ±0.68 | |
| Control | 50.30 ±8.40 | 23:29 | 121.54± 15.13 | 76.92± 8.75 | 188.93 ±32.88 | 106.83±30.13 | 54.9± 12.14 | 132.88 ±58.87 | 1.97 ±1.34 | 0.56± 0.048 | 4.34±0.6 |
a
These data are presented as ranges.
SD: standard deviation; CIMT: carotid intima media thickness; CRP: C-reactive protein; DBP: diastolic blood pressure; EFT: epicardial fat thickness; FBG: fast blood glucose; HDL: high-density lipoprotein; LDL: low-density lipoprotein; SBP: systolic blood pressure; TG: triglyceride.